The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5203831 6420600 I 5203831-3 20060401 20061227 20070105 EXP 234307 GENENTECH, INC. 28 YR F N 20070104 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5203831 1008027002 PS RITUXAN 1 U D
5203831 1008064376 C CYCLOPHOSPHAMIDE 1
5203831 1008064377 C DOXORUBICIN HCL 1
5203831 1008064378 C VINCRISTINE 1
5203831 1008064379 C PREDNISONE TAB 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
5203831 1008027002 DIFFUSE LARGE B-CELL LYMPHOMA

Outcome of event

Event ID OUTC COD
5203831 OT

Reactions reported

Event ID PT
5203831 CAESAREAN SECTION
5203831 DRUG EXPOSURE DURING PREGNANCY
5203831 PRE-ECLAMPSIA

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
5203831 HP

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5203831 1008027002 20060330 20060427